Week Ending December 15th, 2023
Biotech: 6 Transactions (5 Follow-Ons and 1 PIPE) totaling just under $500 Million
Med Tech: No Current Week Transactions
2023 YTD
176 Biotech transactions totaling just under $26 Billion v. 2022: 165 Biotech transactions totaling just under $21 Billion
18 Med Tech transactions totaling just over $1 Billion v. 2022: 10 Med Tech transactions just under $900 Million
Private Transactions
Biotech: 241 Transactions / 76 European Transactions
Med Tech: 137 US Transactions / 38 European Transaction
Major Transactions:
AstraZeneca acquired Icosavax - $800M / $15/share
AbbVie acquired Cerevel Therapeutics - $8.7B / $45/share
Roche acquired Carmot Therapeutics - $2.7B
AbbVie acquired ImmunoGen - $10.1B / $31.26/share
Astellas Pharma acquired Propella Therapeutics - $175M
Ajinomot acquired Forge Biologics - $554M
Comments